Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies
Lu Tang, Yinqiang Zhang, Yu Hu, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-8
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice
Rujul H Parikh, Sagar Lonial
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 3, pp. 275-285
Open Access | Times Cited: 66
T cell exhaustion in malignant gliomas
Matthew B. Watowich, Mark R. Gilbert, Mioara Larion
Trends in cancer (2023) Vol. 9, Iss. 4, pp. 270-292
Open Access | Times Cited: 59
Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer
Zahir Shah, Lei Tian, Zhixin Li, et al.
Cell stem cell (2024) Vol. 31, Iss. 6, pp. 803-817.e6
Closed Access | Times Cited: 28
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics
Tosin Akinsipe, Rania Mohamedelhassan, Ayuba Akinpelu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Improving CAR T-Cell Persistence
Violena Pietrobon, Lauren A. Todd, Anghsumala Goswami, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10828-10828
Open Access | Times Cited: 75
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma
Zi‐Xun Yan, Yan Dong, Q. L. Niu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
Jiawen Huang, Xiaobing Huang, Juan Huang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Engineering chimeric antigen receptor T cells for solid tumour therapy
Longwei Liu, Yunjia Qu, Leonardo Cheng, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 29
The Interplay between T Cells and Cancer: The Basis of Immunotherapy
Christina Chen, Xin Liu, Che‐Yu Chang, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1008-1008
Open Access | Times Cited: 20
Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy
Brian M. Russell, David Avigan
International Journal of Hematology (2023) Vol. 117, Iss. 5, pp. 652-659
Open Access | Times Cited: 17
Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies
Wioletta Olejarz, Karol Sadowski, Daniel Szulczyk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7743-7743
Open Access | Times Cited: 8
Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope
Alejandrina Hernández-López, Mario A. Téllez-González, Paul Mondragón‐Terán, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 39
PD-L1 Overexpression, SWI/SNF Complex Deregulation, and Profound Transcriptomic Changes Characterize Cancer-Dependent Exhaustion of Persistently Activated CD4+ T Cells
Iga Jancewicz, Joanna Szarkowska, Ryszard Konopiński, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4148-4148
Open Access | Times Cited: 36
T cell landscape in the microenvironment of human solid tumors
Enrico Maggi, Enrico Munari, Nadine Landolina, et al.
Immunology Letters (2024) Vol. 270, pp. 106942-106942
Closed Access | Times Cited: 5
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
Sunčica Kapor, Juan F. Santibáñez
Journal of Clinical Medicine (2021) Vol. 10, Iss. 13, pp. 2788-2788
Open Access | Times Cited: 28
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
Qiuqiang Chen, Lingeng Lu, Wenxue Ma
Cancers (2022) Vol. 14, Iss. 23, pp. 5983-5983
Open Access | Times Cited: 21
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming
Maria V. Alvanou, Memnon Lysandrou, Panayota Christophi, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1935-1935
Open Access | Times Cited: 13
Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Fundamentals to therapeutics: Epigenetic modulation of CD8+ T Cell exhaustion in the tumor microenvironment
Maja K. Blake, Patrick M. O’Connell, Yasser A. Aldhamen
Frontiers in Cell and Developmental Biology (2023) Vol. 10
Open Access | Times Cited: 11
Talquetamab in multiple myeloma
Lawrence Liu, Amrita Krishnan
Haematologica (2023) Vol. 109, Iss. 3, pp. 718-724
Open Access | Times Cited: 11
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
Sanjay Chandrasekaran, Christopher Ronald Funk, T. Kleber, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 26
Bruton tyrosine kinase inhibitors preserve anti-CD19 chimeric antigen receptor T-cell functionality and reprogram tumor micro-environment in B-cell lymphoma
Wenjing Luo, Chenggong Li, Jianghua Wu, et al.
Cytotherapy (2023) Vol. 25, Iss. 7, pp. 739-749
Open Access | Times Cited: 10
Cbl-b inhibition improves manufacturing efficiency and antitumoral efficacy of anti-CD19 CAR-T cells
Hao‐Qi Wang, Fei Li, Yuanyuan Feng, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113971-113971
Closed Access
Challenges and opportunities in single-domain antibody-based tumor immunotherapy
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML
Andrew Kent, Lyndsey S. Crump, Eduardo Dávila
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top